Results for sustained response rate translation from English to Maltese

sustained response
rispons sostenut

no sustained response
ebda rispons sostenut

response rate
rata ta’ rispons

overall sustained response
rispons sostenut globali

the sustained response at the end of
fil- każijiet kollha, it- trattament kien għal sena b’ follow- up ta ’ sitt xhur.

sustained virological response rates in children and adolescents
rati ta ’ rispons viroloġiku sostnut fi tfal u adolexxenti kienu simili għal dawk fl- adulti.

the overall sustained response rate after a 24-week treatment duration was 50 %.
ir-rata globali ta’ rispons sostnut wara 24 ġimgħa ta’ kura kienet 50 %.

sustained response was assessed by the response rate six months after the cessation of treatment.
rispons sostnut kien stmat mir-rata ta’ rispons sitt xhur wara l-waqfien tal- kura.

in this subgroup, there was a 92 % (89/97) sustained virological response rate.
f’dan is-sottogrupp, kien hemm rata ta’ rispons viroloġiku sostnut ta’ 92 % (89/97).

in all three treatment groups, sustained virologic response rates were similar.
fil-gruppi ta’ kura kollha t-tlieta lu huma, rati ta’ rispons viroloġiku sostnut kienu simili.

in adult patients receiving interferon in combination with ribavirin, the achieved sustained response rate is 47 %.
f’pazjenti adulti li jkunu qed jirċievu interferon ma’ ribavirin, ir-rata ta’ rispons sostnut li nkisbet hija 47 %.

sustained response rates with pegintron + ribavirin (by ribavirin dose, genotype and viral load)
i/ r rati ta ’ risponsi sostnuti b 'pegintron + ribavirin (bid- doża ta ’ ribavirin, ġenotip u viral load)

sustained response rates with viraferon peg + ribavirin (by ribavirin dose, genotype and viral load)
i/ r rati ta ’ risponsi sostnuti b 'viraferonpeg + ribavirin (bid- doża ta ’ ribavirin, ġenotip u viral load)

table 9 sustained response rates with pegintron + ribavirin (by ribavirin dose, genotype and viral load)
tabella 9 rati ta’ rispons sostnut b’pegintron + ribavirin (skont id-doża ta’ ribavirin, il- ġenotip u l-ammont virali)

the high sustained response rate in this subgroup of patients was identified in an interim analysis (n=49) and prospectively confirmed (n=48).
ir-rata għolja li nkisbet f’dan is-sottogrupp ta’ pazjenti ġiet identifikata f’analiżi li saret waqt li kien għaddej l-istudju (n=49) u kkonfermata b’mod prospettiv (n=48).

(sustained response rate of 61% achieved in a study performed in naïve patients with a ribavirin dose > 10.6 mg/ kg, p < 0.01).
ad p < 0. 01).

for patients with prior failure on therapy with nonpegylated interferon or pegylated interferon and negative at week 12, the sustained response rates were 59 % and 50 %, respectively.
għall-pazjenti li ma kinux irnexxew b’terapija li ngħatat qabel b’interferon mhux pegilat jew interferon pegilat u negattivi f’ġimgħa 12, ir-rati ta’ rispons sostnut kienu ta’ 59 % u 50 %, rispettivament.

table 6 sustained response rates with ribavirin + peginterferon alfa-2b (by ribavirin dose [mg/kg], genotype and viral load)
tabella 6: rati ta’ rispons sostnut b’ribavarin + peginterferon alfa-2b (skont id-doża ta’ ribavarin [mg/kg], ġenotip u viral load)

for patients with prior failure on therapy with non-pegylated interferon or pegylated interferon and negative at week 12, the sustained response rates were 59 % and 50 %, respectively.
għall-pazjenti li kienu fallew għat-terapija li kienet ingħatat qabel b’interferon mhux pegilat jew interferon pegilat u negattivi ma’ ġimgħa 12, it-rati ta’ rispons sostnut kienu 59 % u 50 %, rispettivament.